Literature DB >> 28752840

Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity.

Christian N Paxton1, Dennis P O'Malley2, Andrew M Bellizzi3, Deema Alkapalan3, Yuri Fedoriw4, Jason L Hornick5, Sherrie L Perkins1,6, Sarah T South1,6, Erica F Andersen1,6.   

Abstract

Juvenile xanthogranuloma is a rare histiocytic proliferation primarily affecting infants and young children, characterized by aberrant infiltration of histiocyte-derived cells in the skin, soft tissues and more rarely, visceral organs. Juvenile xanthogranuloma is generally considered to be a benign disorder; most lesions are solitary cutaneous nodules that resolve spontaneously without treatment. However, cases with extracutaneous involvement, multiple lesions, and/or systemic disease often require aggressive therapy. Though molecular studies have provided evidence of clonality in juvenile xanthogranuloma, in support of a neoplastic process, little is known about the genetic profile of juvenile xanthogranuloma. We used molecular inversion probe array technology to evaluate the genomic characteristics (copy number alterations or copy neutral-loss of heterozygosity) of 21 archived cases of juvenile xanthogranuloma (19 solitary, 1 diffuse cutaneous, 1 systemic). Four cases (19%) showed acquired, clonal alterations. Two lesions from a case of diffuse cutaneous juvenile xanthogranuloma showed distinct profiles: JXG-1a contained trisomy 5 and 17 and JXG-1b contained loss of heterozygosity in 5q. The systemic juvenile xanthogranuloma (JXG-2) showed multiple genomic alterations. Only two of 19 solitary juvenile xanthogranulomas showed abnormal genomic profiles: JXG-3 showed gains on 1q and 11q and JXG-4 showed a 7.2 Mb loss in 3p. No recurrent abnormalities were observed among these cases. The presence of non-recurrent copy number alterations in a subset of samples implies that copy number changes are unlikely driving pathogenesis in juvenile xanthogranuloma, but may be acquired during disease progression. The presence of genomic abnormalities in more advanced cases (ie, systemic and diffuse cutaneous juvenile xanthogranuloma) supports this notion, particularly as the advanced cases of juvenile xanthogranuloma presented more genomic complexity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28752840     DOI: 10.1038/modpathol.2017.50

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  27 in total

1.  Solitary (juvenile) xanthogranuloma: a comprehensive immunohistochemical study emphasizing recently developed markers of histiocytic lineage.

Authors:  Rosalind F Sandell; Jodi M Carter; Andrew L Folpe
Journal:  Hum Pathol       Date:  2015-06-10       Impact factor: 3.466

Review 2.  Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.

Authors:  Carl E Allen; D Williams Parsons
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

3.  Constitutional balanced chromosomal rearrangements and neoplasm in children.

Authors:  D R Betts; J Greiner; A Feldges; U Caflisch; F K Niggli
Journal:  J Pediatr Hematol Oncol       Date:  2001-12       Impact factor: 1.289

4.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

5.  Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis.

Authors:  Laura K Conlin; Brian D Thiel; Carsten G Bonnemann; Livija Medne; Linda M Ernst; Elaine H Zackai; Matthew A Deardorff; Ian D Krantz; Hakon Hakonarson; Nancy B Spinner
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

6.  Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas.

Authors:  Helen T Shin; Michael B Harris; Seth J Orlow
Journal:  J Pediatr Hematol Oncol       Date:  2004-09       Impact factor: 1.289

7.  Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells.

Authors:  J H de Graaf; W Timens; R Y Tamminga; W M Molenaar
Journal:  Hum Pathol       Date:  1992-08       Impact factor: 3.466

8.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

9.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Authors:  Marie-Luise Berres; Karen Phaik Har Lim; Tricia Peters; Jeremy Price; Hitoshi Takizawa; Hélène Salmon; Juliana Idoyaga; Albert Ruzo; Philip J Lupo; M John Hicks; Albert Shih; Stephen J Simko; Harshal Abhyankar; Rikhia Chakraborty; Marylene Leboeuf; Monique Beltrão; Sérgio A Lira; Kenneth M Heym; Venetia Bigley; Matthew Collin; Markus G Manz; Kenneth McClain; Miriam Merad; Carl E Allen
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307

10.  High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.

Authors:  Yuker Wang; Victoria E H Carlton; George Karlin-Neumann; Ronald Sapolsky; Li Zhang; Martin Moorhead; Zhigang C Wang; Andrea L Richardson; Robert Warren; Axel Walther; Melissa Bondy; Aysegul Sahin; Ralf Krahe; Musaffe Tuna; Patricia A Thompson; Paul T Spellman; Joe W Gray; Gordon B Mills; Malek Faham
Journal:  BMC Med Genomics       Date:  2009-02-19       Impact factor: 3.063

View more
  4 in total

1.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia.

Authors:  Judith A Ferry
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 2.  The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature.

Authors:  Michaela Höck; Bernhard Zelger; Gisela Schweigmann; Barbara Brunner; Bettina Zelger; Gabriele Kropshofer; Ursula Kiechl-Kohlendorfer
Journal:  BMC Pediatr       Date:  2019-04-24       Impact factor: 2.125

3.  Multiple subcutaneous juvenile xanthogranulomas with a blue hue in a neonate: An atypical presentation.

Authors:  Michael P Ryan; Adam V Nguyen; Matthew J Hay; Brent C Kelly; Sharon S Raimer
Journal:  JAAD Case Rep       Date:  2020-04-24

Review 4.  Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare Inflammatory Entity.

Authors:  Vera Lozovanu; Carmen Emanuela Georgescu; Lavinia Maria Florescu; Carmen Georgiu; Horatiu Silaghi; Andrian Fratea; Cristina Alina Silaghi
Journal:  J Pers Med       Date:  2022-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.